Literature DB >> 11696439

Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases.

M Yamada1, T Sato, T Shimohata, S Hayashi, S Igarashi, S Tsuji, H Takahashi.   

Abstract

Neuronal intranuclear inclusions (NIIs) are a pathological hallmark of CAG repeat diseases. To elucidate the influence of NII formation on intranuclear substructures, we investigated the relationship of NIIs with nuclear bodies in brains of dentatorubral-pallidoluysian atrophy and Machado-Joseph disease. In both diseases, promyelocytic leukemia protein, a major component of the promyelocytic leukemia protein nuclear bodies, altered the normal distribution and was rearranged around NII, forming a single capsular structure. We further demonstrated that NIIs were present in close contact with coiled bodies, a highly dynamic domain that may be involved in the biogenesis of small nuclear ribonucleoproteins. The preferential association of intranuclear polyglutamine aggregates with coiled bodies was also confirmed in the dentatorubral-pallidoluysian atrophy transgenic mouse brain and culture cells expressing mutant atrophin-1. The results suggest that the interaction between NIIs and nuclear bodies may play a role in the pathogenesis of CAG repeat diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696439      PMCID: PMC1867069          DOI: 10.1016/S0002-9440(10)63025-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

Authors:  F C Nucifora ; M Sasaki; M F Peters; H Huang; J K Cooper; M Yamada; H Takahashi; S Tsuji; J Troncoso; V L Dawson; T M Dawson; C A Ross
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

Review 2.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

3.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.

Authors:  D Martindale; A Hackam; A Wieczorek; L Ellerby; C Wellington; K McCutcheon; R Singaraja; P Kazemi-Esfarjani; R Devon; S U Kim; D E Bredesen; F Tufaro; M R Hayden
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

6.  Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.

Authors:  A Kazantsev; E Preisinger; A Dranovsky; D Goldgaber; D Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

7.  Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription.

Authors:  T Shimohata; T Nakajima; M Yamada; C Uchida; O Onodera; S Naruse; T Kimura; R Koide; K Nozaki; Y Sano; H Ishiguro; K Sakoe; T Ooshima; A Sato; T Ikeuchi; M Oyake; T Sato; Y Aoyagi; I Hozumi; T Nagatsu; Y Takiyama; M Nishizawa; J Goto; I Kanazawa; I Davidson; N Tanese; H Takahashi; S Tsuji
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

8.  c-Jun and p53 activity is modulated by SUMO-1 modification.

Authors:  S Muller; M Berger; F Lehembre; J S Seeler; Y Haupt; A Dejean
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

9.  Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA.

Authors:  G Schilling; J D Wood; K Duan; H H Slunt; V Gonzales; M Yamada; J K Cooper; R L Margolis; N A Jenkins; N G Copeland; H Takahashi; S Tsuji; D L Price; D R Borchelt; C A Ross
Journal:  Neuron       Date:  1999-09       Impact factor: 17.173

Review 10.  PML and COP1--two proteins with much in common.

Authors:  J C Reyes
Journal:  Trends Biochem Sci       Date:  2001-01       Impact factor: 13.807

View more
  21 in total

Review 1.  PML nuclear bodies.

Authors:  Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

Review 2.  Cajal bodies in neurons.

Authors:  Miguel Lafarga; Olga Tapia; Ana M Romero; Maria T Berciano
Journal:  RNA Biol       Date:  2016-09-14       Impact factor: 4.652

3.  Polyglutamine expansion alters the dynamics and molecular architecture of aggregates in dentatorubropallidoluysian atrophy.

Authors:  Justyna Hinz; Lothar Lehnhardt; Silke Zakrzewski; Gong Zhang; Zoya Ignatova
Journal:  J Biol Chem       Date:  2011-12-01       Impact factor: 5.157

Review 4.  The role of PML in the nervous system.

Authors:  Paolo Salomoni; Joanne Betts-Henderson
Journal:  Mol Neurobiol       Date:  2010-12-15       Impact factor: 5.590

Review 5.  Nuclear domain 10 of the viral aspect.

Authors:  Yisel A Rivera-Molina; Francisco Puerta Martínez; Qiyi Tang
Journal:  World J Virol       Date:  2013-08-12

6.  Nuclear aggresomes form by fusion of PML-associated aggregates.

Authors:  Lianwu Fu; Ya-Sheng Gao; Albert Tousson; Anish Shah; Tung-Ling L Chen; Barbara M Vertel; Elizabeth Sztul
Journal:  Mol Biol Cell       Date:  2005-07-29       Impact factor: 4.138

7.  Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease.

Authors:  J Lee; Y J Hwang; J H Boo; D Han; O K Kwon; K Todorova; N W Kowall; Y Kim; H Ryu
Journal:  Cell Death Differ       Date:  2011-05-06       Impact factor: 15.828

Review 8.  The Arc of cognition: Signaling cascades regulating Arc and implications for cognitive function and disease.

Authors:  Irina Epstein; Steven Finkbeiner
Journal:  Semin Cell Dev Biol       Date:  2018-05       Impact factor: 7.727

9.  Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's disease.

Authors:  Junghee Lee; Yu Jin Hwang; Jong-Yeon Shin; Won-Chul Lee; Jinhong Wie; Ki Yoon Kim; Min Young Lee; Daehee Hwang; Rajiv R Ratan; Ae Nim Pae; Neil W Kowall; Insuk So; Jong-Il Kim; Hoon Ryu
Journal:  Acta Neuropathol       Date:  2013-03-02       Impact factor: 17.088

10.  Puromycin-based vectors promote a ROS-dependent recruitment of PML to nuclear inclusions enriched with HSP70 and Proteasomes.

Authors:  Diarmuid M Moran; Hong Shen; Carl G Maki
Journal:  BMC Cell Biol       Date:  2009-05-01       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.